Clinical Trial: Screening of Predictive Biomarkers for Therapeutic Efficacy and Research on Drug Resistance Mechanisms of IL-17A Inhibitors in the Treatment of Hidradenitis Suppurativa (China)

Posted On: 2026-08-11

China, Aug. 11 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening of Predictive Biomarkers for Therapeutic Efficacy and Research on Drug Resistance Mechanisms of IL-17A Inhibitors in the Treatment of Hidradenitis Suppurativa'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600129782

Registration Time: 2026/08/10

Type: Interventional study

Primary Sponsor: Chinese People's Liberation Army Air Force Specialty Medical Center

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=333668

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Screening of Predictive Biomarkers for Therapeutic Efficacy and Research on Drug Resistance Mechanisms of IL-17A Inhibitors in the Treatment of Hidradenitis Suppurativa (China)